Claire J. Creutzfeldt, MD; Robert G. Holloway, MD, MPH
has audio
JAMA. 2020;323(2):115-116. doi:10.1001/jama.2019.19652
This Viewpoint discusses the reality that most decisions about treatment for incapacitated patients involve surrogate assessments of patients’ past values at their baseline health, and it proposes that more ethical and informed decision-making would help surrogates consider the degree to which their loved one might be able to adapt to and value a future health state at what is a higher level of disability.
-
Conversations with Dr Bauchner:
Treatment Decisions for a Future Self
Sally A. Santen, MD, PhD; Robin R. Hemphill, MD, MPH; Martin Pusic, MD, PhD
JAMA. 2020;323(2):117-118. doi:10.1001/jama.2019.21081
This Viewpoint discusses 2 forces that can lead to the decline in competency in medicine over time, deterioration in ability with age and decrease in opportunities for maintenance and self-improvement, includes considerations that may be helpful to addressing competency decline.